Safety – Smoke Master

Official Publications on the Safety of Vapes: Caution Should Not Cast Doubt on Established Facts

admin — Tue, 25 Aug 2026 15:26:14 +0000

The way health authorities communicate about vaping can influence whether smokers understand, reject or embrace safer alternatives. As evidence supporting vaping as a smoking-cessation tool continues to strengthen, researchers are increasingly recognising that consumer perceptions and experiences are themselves important public-health outcomes.

This is where consumer-reported outcome measures (CROMs) can add valuable insight. As discussed recently in a GFN Science Lab session featuring Christelle Chrea, CROMs are designed to capture what consumers think, feel, and do when using tobacco and nicotine products. They include straightforward descriptive measures, such as frequency and patterns of use, alongside psychometric measures examining concepts such as perceived risk, dependence, satisfaction and attitudes.

That distinction is particularly important in vaping. A product can have a substantially different risk profile from cigarettes, yet if smokers believe the two products are equally dangerous, they may have little incentive to switch.

Risk perception is becoming a public-health problem

Recent British data illustrate the scale of the problem. The 2026 Action on Smoking and Health (ASH) survey of more than 13,000 adults found that 54% of respondents believed vaping was as harmful as or more harmful than smoking. Among smokers who had never vaped, the proportion was even higher, at 61%. Sadly, only 29% correctly recognised that vaping is less harmful than smoking.

This matters because perceptions of relative risk can influence behaviour. Someone who believes switching from cigarettes to vaping merely exchanges one form of serious harm for another may reasonably conclude that there is little reason to make the change. Yet the evidence base does not support treating smoking and vaping as equivalent.

Research has consistently shown that vapes are significnatly safer than cigarettes since they do not burn tobacco or produce tar and carbon monoxide, two major components of tobacco smoke. It has also been noted that vaping carries only a small fraction of the risk of smoking, while acknowledging that it may not be risk-free and that the long-term effects are not yet fully known. That distinction—risk-free versus lower-risk—is central to effective tobacco harm reduction.

When caution creates confusion

NHS guidance previously described vaping as “far less harmful than cigarettes”, before changing the wording in July 2026 to “likely to be far less harmful”. Earlier NHS Better Health material similarly used the phrase “substantially less harmful” before later shortening it to “less harmful”.

Recent changes to NHS wording, caught by the sharp eye of tobacco policy researcher Clive Bates, have nevertheless raised questions about whether increasingly qualified language could unintentionally reinforce public uncertainty. Bates highlighted that NHS guidance previously described vaping as “far less harmful than cigarettes”, before changing the wording in July 2026 to “likely to be far less harmful”. Earlier NHS Better Health material similarly used the phrase “substantially less harmful” before later shortening it to “less harmful”.

Acknowledging scientific uncertainty is not inherently wrong. Vaping has not existed in its current form for several decades, and continued research into long-term effects is entirely appropriate. The problem arises when caution obscures the magnitude of the difference between vaping and smoking.

Simply saying that one product is “less harmful” than another provides almost no information about the size of the difference. A product could theoretically be 5%, 50% or 95% less harmful and still satisfy that description. For smokers deciding whether to switch, that distinction is not semantic—it could be life-changing.

The cessation evidence is becoming harder to ignore

The strongest argument for clear risk communication is the growing evidence that nicotine vapes can actually help smokers quit. The latest Cochrane living systematic review, incorporating evidence available through March 2025, included 104 studies involving more than 30,000 adults who smoked. It found high-certainty evidence that nicotine e-cigarettes increase smoking-cessation rates compared with nicotine replacement therapy (NRT). The review estimated a relative risk of 1.59 compared with NRT, translating to approximately four additional quitters for every 100 people treated.

Cochrane also found that nicotine e-cigarettes probably outperform non-nicotine vapes. Importantly, the review found no evidence of serious harm from nicotine e-cigarettes, although the authors emphasised that larger, longer studies are still needed to assess long-term safety. This evidence is consistent with earlier Cochrane network meta-analysis findings, which placed nicotine e-cigarettes alongside varenicline and cytisine among the most effective pharmacological approaches to smoking cessation.

The details behind the numbers

CROMs can help bridge the gap between clinical evidence and real-world behaviour. Researchers can measure whether someone has stopped smoking, but understanding why they switched (or why they returned to cigarettes) requires examining perceptions, satisfaction, dependence, product preferences and the subjective experience of using the alternative.

For example, ASH’s 2026 data show that 60% of current adult vapers in Great Britain are former smokers, representing approximately 3.3 million people. Another 1.7 million current vapers continue to smoke. Those figures demonstrate both the potential and the complexity of vaping as a harm-reduction intervention. Switching completely away from combustible tobacco is the key objective, but consumers’ experiences with nicotine delivery, flavours, convenience and cravings can influence whether that transition succeeds.

Clear communication is essential for harm reduction

Exaggerated risk perceptions can undermine the very behaviour public-health policy seeks to encourage. The NHS itself says that people who switch completely from smoking to vaping reduce their exposure to toxins associated with cancer, lung disease, heart disease and stroke.

That message does not require claiming that vaping is harmless. It requires communicating relative risk accurately and proportionately. For tobacco harm reduction to work, smokers need to understand not simply that vaping is “different” from smoking, but why the difference matters. CROMs can help researchers understand whether public-health messaging is achieving that goal.

As smoking continues to cause millions of preventable deaths worldwide, communicating uncertainty should not inadvertently create uncertainty about what is already well established. For an adult who would otherwise continue smoking, moving completely from combustible cigarettes to a regulated nicotine alternative represents a meaningful reduction in exposure to the toxic products of combustion.

The challenge for policymakers and health authorities is therefore not to eliminate every expression of uncertainty. It is to ensure that caution does not become confusion—and that confusion does not keep smokers smoking.

Beyond the Smoker: Study Shows How Nicotine Alternatives Improve Family Life in Multiple Ways

Source link

Texas Officials Call Hemp A Crisis While Bigger Public Safety Threats Go Unanswered (Op-Ed)

admin — Thu, 13 Aug 2026 19:47:15 +0000

“Texas can protect children and consumers without rebuilding the drug war.”

By Michael A. Davis

Texas officials have spent years treating hemp-derived THC as if it were the greatest danger facing the state. Now the crackdown is no longer political theater.

Beginning July 31, Texas restored a controlled substance schedule that allows products labeled as containing delta-8 THC—or found to contain more than trace amounts of certain tetrahydrocannabinols—to be detained and referred to law enforcement.

That does not mean every hemp product is illegal. Products that comply with the state’s delta-9 THC limit remain legal. But it does mean many products that adults bought openly from registered businesses have suddenly been pushed out of the regulated marketplace.

Texas leaders may call that a public-safety victory. I see a policy that could make the market less safe.

I write from the perspective of someone who has lived through incarceration and spent years working on reentry. I know how quickly lawmakers can turn a complicated social problem into a criminal offense.

I also know what happens after the speeches end. The politician moves to the next issue, while ordinary people live with arrests, records, lost jobs and closed doors.

There are legitimate concerns about intoxicating hemp products. Some have been sold in packaging that appeals to children. Potency can be inconsistent. Labels can be confusing, and testing standards have not always given consumers the protection they deserve.

No responsible advocate should dismiss those problems. But those problems call for regulation, not denial.

Texas already showed that it knows how to build guardrails. The state imposed a minimum purchase age of 21 and required government-issued identification. Regulators adopted rules involving labeling, testing, packaging and inspections. Those protections could have been strengthened with uniform dosage limits, random state testing, tougher penalties for businesses that sell to minors and clear rules against child-oriented advertising.

Instead, Texas chose to remove certain products from legal shelves while leaving demand in place.

That is where the real danger begins.

A licensed retailer can be inspected. Its products can be tested. A batch can be traced or recalled. A business can lose its license for selling to a child. An illegal seller has no license to lose, no testing requirement to follow and no reason to check identification.

A teenager who walks into a compliant smoke shop should be asked for identification. A dealer operating through social media, a parking lot or an unregulated delivery network will not care whether the customer is 17 or 37.

This crackdown does not eliminate hemp-derived THC. It creates more room for untested products, counterfeit labels and sellers who cannot be held accountable. It may also give organized criminal networks another market to exploit.

That does not mean every illegal sale is tied to a cartel, and we should not make claims the evidence cannot support. But when government closes a legal channel without ending consumer demand, illegal suppliers gain an opening. That is basic economics, not fearmongering.

Texas applies a different standard to alcohol.

Alcohol is sold in grocery stores, convenience stores, restaurants, stadiums and entertainment districts. It is present in homes and at parties across the state. A teenager may never need to fool a cashier to get it; the alcohol may already be in a refrigerator or handed over by an older friend.

Texas does not respond by outlawing beer, wine and liquor for adults. It licenses sellers, checks identification, taxes the products and penalizes violations. The system is imperfect, but the principle is clear: Adult access can coexist with rules designed to protect children.

Alcohol and hemp are not identical. They do not have to be identical for the double standard to matter. If Texas believes regulation can reduce the risks associated with alcohol, it should explain why regulation is suddenly considered impossible when the product is hemp-derived THC.

The imbalance is even harder to defend when we look at the crises Texas already faces.

The state Department of State Health Services says drug poisoning deaths increased 68 percent from 2019 to 2024. In 2023, drug poisoning was the leading cause of injury-related death for Texans ages 24 to 69. Families are still being devastated by fentanyl, while communities also confront gun violence, violent crime, untreated mental-health needs and unaffordable health care.

Those problems require sustained investment in prevention, treatment, enforcement and recovery. They are expensive, complicated and politically difficult. Banning a product is simpler. It creates a headline and allows leaders to declare victory before the consequences are measured.

We should also be honest about the economic interests surrounding this debate.

Hemp-derived THC beverages are becoming real competitors in the broader adult-beverage market. NielsenIQ reported that mainstream retail sales reached $239 million over the latest 52-week period, an increase of 135 percent from the prior year. Some consumers are replacing a beer, glass of wine or cocktail with a low-dose THC drink.

Some alcohol businesses see that market as an opportunity and have begun selling or distributing THC beverages. Others may see it as a threat. That division matters because “the alcohol industry” is not a single voice. Still, political contributions from people connected to alcohol distribution deserve public scrutiny when Texas leaders push policies that could remove a competing product.

Campaign-finance records have prompted questions about major donations to Lt. Gov. Dan Patrick (R), who led efforts to restrict hemp products in the most recent legislative session, from John Nau, a longtime beer distribution executive. A contribution does not prove a deal, and it would be irresponsible to claim otherwise. But Texans are entitled to ask whether established industries have greater access to political power than the small businesses and consumers who will bear the cost of prohibition.

Following the money is not the same as alleging corruption. It is part of holding government accountable.

Texas can protect children and consumers without rebuilding the drug war.

Require every intoxicating product to be sold only to adults 21 and older. Mandate reliable identification checks, child-resistant packaging and plain labeling. Establish reasonable per-serving and per-package THC limits. Require independent laboratory testing, scannable batch information and random state verification. Punish businesses that mislabel products or sell to minors. Fund public education and impaired-driving enforcement.

Those are not weak measures. They are what serious regulation looks like.

Public safety should be measured by harm reduced, not products banned. If the result of Texas’s crackdown is that adults turn from accountable retailers to illegal sellers, then the state will have created the very danger it claimed to prevent.

The question is not whether hemp should have rules. It should.

The question is whether Texas wants rules that protect people—or prohibition that protects politics.

Michael A. Davis is an Austin-based writer, author and reentry advocate whose work examines Texas politics, criminal justice, public policy and communities too often overlooked by those in power. He is the author of the books “The Road to Reentry,” “Pursuing Redemption,” “Reclaiming Freedom” and “The Mind You Inherited.”

Image element courtesy of AnonMoos.

Source link